Skip to content
Lower risk Drug recall · FDA · Published August 27, 2026

Macleods Olanzapine Tablets 5mg Recall: Impurities May Cause Harm

Macleods Pharmaceuticals recalls 5mg Olanzapine tablets due to impurities that could pose health risks. Affected products have specific lot numbers and expiration dates. Consumers should contact the manufacturer for details.

🇺🇸 FDA recall #D-0867-2026DrugMacleods ›
✎ GovInfoNow plain-language explainer

Macleods Pharmaceuticals is recalling 5mg Olanzapine tablets because they contain impurities that may cause health risks. This recall affects specific batches produced in India with a particular expiration date. The issue does not involve immediate danger but requires action to ensure safety. Read more at govinfonow.com/recall/1287573-macleods-olanzapine-tablets-5mg-recall-impurities-may-cause-harm.

Source Summary by GovInfoNow · govinfonow.com/recall/1287573-macleods-olanzapine-tablets-5mg-recall-impurities-may-cause-harm · Updated October 6, 2026 · FDA enforcement record: FDA #D-0867-2026

Cite this page

“Macleods Olanzapine Tablets 5mg Recall: Impurities May Cause Harm.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/1287573-macleods-olanzapine-tablets-5mg-recall-impurities-may-cause-harm. Based on FDA recall #D-0867-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0867-2026%22&limit=1).

The FDA announced on Aug. 27, 2026, that Macleods Pharmaceuticals Limited is recalling Olanzapine Tablets, USP 5 mg due to failed impurity specifications. The recall affects 22,032 bottles distributed nationwide.

How to tell if you have it

  • Brand: Macleods
  • Product: Olanzapine Tablets, USP 5 mg, 30-count bottle
  • NDC: 33342-068-07
  • Lot code: BOB22321A
  • Expiration date: 07-31-2027
  • Quantity: 22,032 bottles

The hazard

According to the FDA, the recalled Olanzapine Tablets contain organic and unspecified impurities above specification. The agency classified this as a Class III recall.

Context

GovInfoNow's records show other recent recalls of similar products include Somerset Therapeutics Dexamethasone Injection Recall: Impurities May Cause Harm (2026-02-04), Ajanta Pharma Fluphenazine Tablets Recall: Impurity Risk in 100-Count Bottles (2026-08-25), and Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall: N-Nitroso Impurity Risk (2026-01-21).

How to tell if you have this one

Check for the product name 'Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only'. The lot number is BOB22321A and the expiration date is July 31, 2027. This product was manufactured in India and distributed by Macleods Pharma USA, Inc.

  • Brand
    Macleods
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot number BOB22321A and expiration date of July 31, 2027 on the product label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 34 days after the firm started it.

1. Firm started the recall: Aug 27, 202612. FDA classified it Class III: Sep 22, 202623. Published in FDA’s Enforcement Report: Sep 30, 202634. Added to GovInfoNow: Oct 6, 202642026
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0867-2026 (August 27, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0867-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA